Embria Gains Exclusive International Distribution and EU Approval for eXselen

CEDAR RAPIDS, IA, October 26, 2005 - Embria (TM) Health Sciences, manufacturer of natural ingredients for use in high-quality, human nutritional products, announced exclusive international distribution partnerships with Galena Química e Farmacêutica, Ltda. and Livingstone, Scott (Healthcare) & Co., Ltd. These partnerships mark the first time Embria's eXselen (TM), an organic selenium yeast ingredient, has been available for purchase in South America and the European Union. Galena will distribute eXselen to pharmaceutical and nutraceutical outlets throughout Brazil. Livingstone will exclusively supply manufacturers in Spain and the UK with eXselen, as well as distribute it throughout the European Union.

"It is of the utmost importance to Embria Health Sciences that our international distributors are firmly established and well-respected, and we are confident that Galena and Livingstone will be successful in providing their respective countries' manufacturers with our high-quality selenomethionine supplements," said Embria Health Sciences president, Paul Faganel. "Additionally, we are pleased to announce that Livingstone, Scott
(Healthcare) & Co., Ltd. has been granted derogation from the European Union Food Supplements Directive and is able to commercialize eXselen throughout the European Union."

Selenium supplementation elevates selenium content in muscle tissue, liver tissue and blood serum, which allows the human body full opportunity to receive all potential benefits associated with the mineral. In addition to being an antioxidant that can protect cells from damage from free radicals, selenium has been found necessary for several important biological processes, including immune response and thyroid function.

Embria's eXselen is pure, all-natural and fully pasteurized. The selenium yeast growth process used in the manufacturing of eXselen produces high levels of selenomethionine, an organic form of selenium that rapidly metabolizes within the body to yield high bioavailability and retention.
Additionally, beneficial B vitamins and glucans are found in the yeast used in the manufacturing of eXselen.

Galena Química e Farmacêutica, Ltda., www.galena.com.br, is the largest importer and distributor of pharmaceutical and food/feed grade raw materials in Brazil. Established in 1987, Galena is certified by the norms of ISO 9001 by German DQS. Galena pharmacists Ranan Katz and Agenor Giulette, Jr., guide the organization's distribution of raw materials for use in pharmaceutical compounds and industrial food and veterinarian products.

Livingstone, Scott (Healthcare) & Co. Ltd. holds decades of experience in the promotion of pharmaceutical and nutraceutical products throughout the UK and Europe. They specialize in the trade marking, patenting and commercialization of pharmaceutical products under the direction of Stephen Minter, Ph.D. and Allan Syms, Ph.D.

Embria Health Sciences combines science and nature to bring high-quality, research-based natural ingredients to the global human nutrition market.
Embria's key products are manufactured using a proprietary technology, which produces vital metabolites that deliver nutritional benefits and support increased bioavailability. This premier technology is based on a similar process pioneered by Embria's parent company, Diamond V (R) Mills, Inc., a leader in animal nutrition ingredients and fermented yeast products since 1943, which has set the standard in the animal nutrition industry for more than 60 years.

For more information on Embria Health Sciences please visit www.embriahealth.com or contact Amanda Holty at 801.538.0777 ext. 106, [email protected].

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.